Search Results 1171-1180 of 18411 for prednisone
If the subject is currently receiving an oral corticosteroid, he or she is eligible if the dose is equivalent to or less than prednisone 20 mg/day or ...
Patients receiving therapy with oral prednisone or glucocorticoid equivalent in the last 4 weeks. Patients treated with low dose oral prednisone or ...
Subjects receiving replacement therapy of 10 mg of prednisone (or the equivalent hydrocortisone dose) per day are eligible. - Receipt of live vaccines ...
Stable immunosuppressive therapy (including prednisone) related to vasculitis for at least 12 weeks. No change in medications in the past 12 weeks made with ...
Oral corticosteroid therapy (prednisone prescribed at a stable dose ≤ 30 mg/day or budesonide prescribed at a stable dose of ≤ 9 mg/day) provided the dose ...
Oral corticosteroids equivalent to ≤ 10 mg/day prednisone if started at least ≤ 2 weeks prior to randomization. Inhaled and topical corticosteroids are ...
A condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalent) or other immunosuppressive medications within 14 days ...
... prednisone (or equivalent). Patients who are on an active steroid taper at the time of randomization must finish prior to beginning study treatment ...
The fireman you're about to meet saw firsthand the destruction on 9/11. At the time he was also a medical student, and today his experience continues to ...
Pramipexole is used to treat Parkinson disease. It may be used alone or in combination with other medicines (eg, levodopa). Pramipexole is a dopamine agonist ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!